VARIABLE INTEREST ENTITY (Additional Information) (Details) - USD ($) |
3 Months Ended | |||
|---|---|---|---|---|
Jun. 10, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
Sep. 17, 2024 |
|
| Variable Interest Entity [Line Items] | ||||
| Deemed capital contribution related to the deconsolidation of a VIE | $ 3,648,425 | |||
| Additional paid in capital | $ 75,715,942 | $ 72,867,424 | $ 8,407,380 | |
| Aikawa Medical Management Inc | ||||
| Variable Interest Entity [Line Items] | ||||
| Collection of loan receivable from a VIE | $ 5,195,128 | |||
| Deemed capital contribution related to the deconsolidation of a VIE | 3,648,425 | |||
| Net assets | $ 1,546,703 |
| X | ||||||||||
- Definition Deemed capital contribution related to the deconsolidation of a VIE No definition available.
|
| X | ||||||||||
- Definition Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of net assets (liabilities). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|